Publication | Open Access

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

MedicineMalignant Blood DisorderImmunologyBronchial NeoplasmMetronomic ChemotherapyOncologyRadiation OncologyPretreatment NeutrophilLung CancerFirst-line Platinum-based Chemotherapy